About CardioNet
CardioNet is a company based in Conshohocken (United States) founded in 1999. CardioNet has raised $141.9 million across 6 funding rounds from investors including IDEO, Tekla Capital Management and Guidant. CardioNet has completed 3 acquisitions, including Biomedical Systems, Cardiocore and Ecgscanning. CardioNet offers products and services including MCOT, ePatch, Implantable Device Monitoring, and Telehealth. CardioNet operates in a competitive market with competitors including Tyto Care, Edwards Lifesciences, BioIntelliSense, Endotronix and Athelas, among others.
- Headquarter Conshohocken, United States
- Stage Public
-
Sectors
HealthcareTechnology
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Biotelemetry, Inc.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$141.9 M (USD)
in 6 rounds
-
Latest Funding Round
$6.9 M (USD), Post-IPO
Apr 27, 2021
-
Investors
IDEO
& 5 more
-
Employee Count
Not available
-
Investments & Acquisitions
Biomedical Systems
& 2 more
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of CardioNet
CardioNet is a publicly listed company on the NASDAQ with ticker symbol BEAT in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of CardioNet
CardioNet offers a comprehensive portfolio of products and services, including MCOT, ePatch, Implantable Device Monitoring, and Telehealth.
Mobile system for detecting and reporting arrhythmias remotely.
Wearable device for prolonged ECG recording and analysis.
System for tracking implanted cardiac devices from afar.
Platform enabling remote consultations and patient support.
Funding Insights of CardioNet
CardioNet has successfully raised a total of $141.9M across 6 strategic funding rounds. The most recent funding activity was a Post-IPO round of $6.9 million completed in April 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in CardioNet
CardioNet has secured backing from 6 investors, including venture fund and institutional investors. Prominent investors backing the company include IDEO, Tekla Capital Management and Guidant.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Locked | Locked | Locked | |
|
Biomedical investment financing and active management services.
|
Locked | Locked | Locked | |
|
Support is provided for life science ventures by BioFrontier.
|
Locked | Locked | Locked |
Investor details for CardioNet
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by CardioNet
CardioNet has strategically engaged in corporate development activities, having acquired 3 companies. Notable acquisitions include Biomedical Systems, Cardiocore and Ecgscanning.
Investment portfolio details for CardioNet
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Cardiac core lab services including ECG and echocardiography are provided.
|
Locked | Locked | 1992 | Locked | |
|
Provider of specialized clinical trial services like cardiac safety testing, imaging and eCOA related services
|
Locked | Locked | 1975 | Locked | |
|
ECG scanning services are provided by Ecgscanning.
|
Locked | Locked | 0 | Locked |
Complete acquisition details for CardioNet
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - CardioNet
Detailed financials for CardioNet
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Cardionet Comparisons
Peer comparison for CardioNet
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of CardioNet
CardioNet operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Tyto Care, Edwards Lifesciences, BioIntelliSense, Endotronix and Athelas, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Medical consultations are facilitated via self-exams and remote diagnostic devices.
|
|
| Locked | Locked | Locked |
Medical devices for structural heart disease are developed and provided.
|
|
| Locked | Locked | Locked |
Vital signs are monitored via a single-use patch and platform.
|
|
| Locked | Locked | Locked |
Miniaturized wireless implantable sensors are developed for hemodynamic monitoring.
|
|
| Locked | Locked | Locked |
Provider of smart solutions for monitoring heart rate, weight, and blood pressure
|
|
| Locked | Locked | Locked |
Remote monitoring platform for tracking patient activity
|
Detailed competitors of CardioNet
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Cardionet
Complete news archive for CardioNet
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about CardioNet
CardioNet was founded in 1999 and raised its 1st funding round 4 years after it was founded.
CardioNet is headquartered in Conshohocken, United States. It is registered at Conshohocken, Pennsylvania, United States.
CardioNet is a funded company, having raised a total of $141.9M across 6 funding rounds to date.
CardioNet was founded in 1999 and is based in Conshohocken, United States. Operations center on the healthcare sector, specifically the diagnosis and monitoring of cardiac arrhythmias. Services include Mobile Cardiac Outpatient Telemetry (MCOT), event monitoring, and Holter monitoring. MCOT utilizes a lightweight, patient-worn sensor attached to electrodes to capture two-channel ECG data, tracking heart electrical activity in outpatient settings.
CardioNet's top competitors include Tyto Care, Endotronix and Athelas.
CardioNet offers MCOT, ePatch, Implantable Device Monitoring, and Telehealth.
Yes, CardioNet is publicly traded on NASDAQ under the ticker symbol BEAT.
CardioNet has made 3 acquisitions, including Biomedical Systems, Cardiocore, and Ecgscanning.
CardioNet has 6 investors. Key investors include IDEO, Tekla Capital Management, Guidant, IngleWood Ventures, and Sanderling Ventures.
The ticker symbol of CardioNet is BEAT on NASDAQ.